Do gender and the END1 gene modify the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy?
Gender and the END1 gene are identified as modifiers of the hypertrophic phenotype in patients with hypertrophic cardiomyopathy.
Our results show that gender and the END1 gene modify the phenotypic expression of hypertrophy in patients with HCM.
Brugada et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: